Yukako Nakagami1, Hiroaki Kubo2, Ryoko Katsuki2, Tomomichi Sakai3, Genichi Sugihara1, Chisako Naito4, Hiroyuki Oda3, Kohei Hayakawa2, Yuriko Suzuki5, Daisuke Fujisawa6, Naoki Hashimoto7, Keiji Kobara8, Tetsuji Cho9, Hironori Kuga10, Kiyoshi Takao10, Yoko Kawahara6, Yumi Matsumura11, Toshiya Murai1, Koichi Akashi12, Shigenobu Kanba2, Kotaro Otsuka13, Takahiro A Kato14. 1. Department of Psychiatry, Kyoto University Graduate School of Medicine, Shogoin-Kawaharacho 54, Kyoto 606-8507, Japan. 2. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. 3. Aso Iizuka Hispital, Iizuka, 3-83 Yoshio, machi, Iizuka, Fukuoka 820-0018, Japan. 4. Integrated Clinical Education Center, Patient Safety Unit, Kyoto University Hospital, Shogoin-Kawaharacho 54, Kyoto 606-8507, Japan. 5. Department of Adult Mental Health, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8553, Japan. 6. Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. 7. Department of Psychiatry, Hokkaido University Graduate School of Medicine, North 15, West 7, Sapporo 060-8638, Japan. 8. Shimane Prefectural Counseling Center for Physical and Mental Health, 1741-3 Higashi-Tsuda-Cho, Matsue, Shimane 690-0011, Japan. 9. Mie Prefectural Mental Medical Center, 1-12-1 Shiroyama, Tsu, Mie 514-0818, Japan. 10. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan; Division of Clinical Research, National Hospital Organization, Hizen Psychiatric Center, 160 Mitsu, Yoshinogari-cho, Kanzaki-gun, Saga 842-0192, Japan. 11. Patient Safety Unit, Kyoto University Hospital, Shogoin-Kawaharacho 54, Kyoto 606-8507, Japan. 12. Clinical Education Center, Kyushu University Hospital, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. 13. Department of Neuropsychiatry, School of Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan. 14. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. Electronic address: takahiro@npsych.med.kyushu-u.ac.jp.
Abstract
BACKGROUND: Suicide is a crucial global health concern and effective suicide prevention has long been warranted. Mental illness, especially depression is the highest risk factor of suicide. Suicidal risk is increased in people not only with mental illness but also with physical illnesses, thus medical staff caring for physically-ill patients are also required to manage people with suicidal risk. In the present study, we evaluated our newly developed suicide intervention program among medical staff. METHODS: We developed a 2-h suicide intervention program for medical staff, based on the Mental Health First Aid (MHFA), which had originally been developed for the general population. We conducted this program for 74 medical staff members from 2 hospitals. Changes in knowledge, perceived skills, and confidence in early intervention of depression and suicide-prevention were evaluated using self-reported questionnaires at 3 points; pre-program, immediately after the program, and 1 month after program. RESULTS: This suicide prevention program had significant effects on improving perceived skills and confidence especially among nurses and medical residents. These significant effects lasted even 1 month after the program. LIMITATIONS: Design was a single-arm study with relatively small sample size and short-term follow up. CONCLUSIONS: The present study suggests that the major target of this effective program is nurses and medical residents. Future research is required to validate the effects of the program with control groups, and also to assess long-term effectiveness and actual reduction in suicide rates.
BACKGROUND: Suicide is a crucial global health concern and effective suicide prevention has long been warranted. Mental illness, especially depression is the highest risk factor of suicide. Suicidal risk is increased in people not only with mental illness but also with physical illnesses, thus medical staff caring for physically-ill patients are also required to manage people with suicidal risk. In the present study, we evaluated our newly developed suicide intervention program among medical staff. METHODS: We developed a 2-h suicide intervention program for medical staff, based on the Mental Health First Aid (MHFA), which had originally been developed for the general population. We conducted this program for 74 medical staff members from 2 hospitals. Changes in knowledge, perceived skills, and confidence in early intervention of depression and suicide-prevention were evaluated using self-reported questionnaires at 3 points; pre-program, immediately after the program, and 1 month after program. RESULTS: This suicide prevention program had significant effects on improving perceived skills and confidence especially among nurses and medical residents. These significant effects lasted even 1 month after the program. LIMITATIONS: Design was a single-arm study with relatively small sample size and short-term follow up. CONCLUSIONS: The present study suggests that the major target of this effective program is nurses and medical residents. Future research is required to validate the effects of the program with control groups, and also to assess long-term effectiveness and actual reduction in suicide rates.
Authors: Masatsugu Orui; Maiko Fukasawa; Naoko Horikoshi; Yuriko Suzuki; Norito Kawakami Journal: Int J Environ Res Public Health Date: 2020-06-26 Impact factor: 3.390
Authors: Sara Wakai; Elizabeth A Schilling; Robert H Aseltine; Ellen W Blair; Jill Bourbeau; Andrea Duarte; Linda S Durst; Patricia Graham; Nancy Hubbard; Kimberly Hughey; Deborah Weidner; Amanda Welsh Journal: SAGE Open Med Date: 2020-06-16